Advanced HER2-Negative Breast Carcinoma: Clinical Trials

1 trial for Advanced HER2-Negative Breast Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Withdrawn 1

Follow Advanced HER2-Negative Breast Carcinoma: new trials by email Literature Review of Advanced HER2-Negative Breast Carcinoma trials Research Report on Advanced HER2-Negative Breast Carcinoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Ribociclib and Palbociclib on Tumor and Blood Characteristics in Patients With Metastatic Breast Cancer
Best Practice, Biopsy, Biospecimen Collection - Advanced Breast Adenocarcinoma, Advanced HER2-Negative Breast Carcinoma
Not applicableWithdrawnCity of Hope Medical Center2022-07-032022-06-09

Interventions

Biopsy (1)  ·  Practice Guidelines as Topic (1)  ·  Standard of Care (1)

Sponsors

City of Hope Medical Center (1)

Top investigators

Yuan Yuan (1)

NIH funding

P30CA033572 (1)